Contemporary Clinical Trials

Papers
(The H4-Index of Contemporary Clinical Trials is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease83
Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials63
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline60
Inclusion and diversity in clinical trials: Actionable steps to drive lasting change57
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the 53
The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design50
COVID-19 vaccines: Considering sex differences in efficacy and safety47
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis a45
Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 201942
Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome40
Using digital technologies in clinical trials: Current and future applications40
Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications39
RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse36
Demographic diversity of participants in Pfizer sponsored clinical trials in the United States36
Sense2Stop: A micro-randomized trial using wearable sensors to optimize a just-in-time-adaptive stress management intervention for smoking relapse prevention35
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation33
Implementation of platform trials in the COVID-19 pandemic: A rapid review29
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clini28
Open Dialogue compared to treatment as usual for adults experiencing a mental health crisis: Protocol for the ODDESSI multi-site cluster randomised controlled trial26
Current druggable targets for therapeutic control of Alzheimer's disease25
Harnessing mobile technology to reduce mental health disorders in college populations: A randomized controlled trial study protocol25
Innovative trial designs and analyses for vaccine clinical development23
DO-HEALTH: Vitamin D3 - Omega-3 - Home exercise - Healthy aging and longevity trial - Design of a multinational clinical trial on healthy aging among European seniors23
0.044762849807739